Most Popular Articles : Clinical Nuclear Medicine

Secondary Logo

Journal Logo

Most Popular Articles

Evaluation of LAT1 Expression in Patients With Lung Cancer and Mediastinal Tumors: 18F-FBPA PET Study With Immunohistological Comparison

Watabe, Tadashi; Ose, Naoko; Naka, Sadahiro; More

Clinical Nuclear Medicine. 48(10):853-860, October 2023.

Feasibility and Therapeutic Potential of 177Lu–Fibroblast Activation Protein Inhibitor–46 for Patients With Relapsed or Refractory Cancers: A Preliminary Study

Assadi, Majid; Rekabpour, Seyed Javad; Jafari, Esmail; More

Clinical Nuclear Medicine. 46(11):e523-e530, November 2021.

Impact of CXCR4-Directed PET/CT on Staging and Proposed Oncologic Management in Patients With Digestive System Tumors

Weich, Alexander; Serfling, Sebastian E.; Schlötelburg, Wiebke; More

Clinical Nuclear Medicine. 48(7):586-593, July 2023.

First Clinical Experience With [68Ga]Ga-FAPI-46-PET/CT Versus [18F]F-FDG PET/CT for Nodal Staging in Cervical Cancer

Wegen, Simone; Roth, Katrin Sabine; Weindler, Jasmin; More

Clinical Nuclear Medicine. 48(2):150-155, February 2023.

Visualization of Fibroblast Activation After Myocardial Infarction Using 68Ga-FAPI PET

Kessler, Lukas; Kupusovic, Jana; Ferdinandus, Justin; More

Clinical Nuclear Medicine. 46(10):807-813, October 2021.

Combined 18F-FDG PET/CT Radiomics and Sarcopenia Score in Predicting Relapse-Free Survival and Overall Survival in Patients With Esophagogastric Cancer

Anconina, Reut; Ortega, Claudia; Metser, Ur; More

Clinical Nuclear Medicine. 47(8):684-691, August 2022.

Somatostatin Receptor-Directed PET/CT for Therapeutic Decision-Making and Disease Control in Patients Affected With Small Cell Lung Cancer

Serfling, Sebastian E.; Hartrampf, Philipp E.; Zhi, Yingjun; More

Clinical Nuclear Medicine. 48(4):309-314, April 2023.

Topical 188Re Ionizing Radiation Therapy Exerts High Efficacy in Curing Nonmelanoma Skin Cancer

Tietze, Julia K.; Heuschkel, Martin; Krönert, Maila I. C.; More

Clinical Nuclear Medicine. 48(10):869-876, October 2023.

Prognostic Impact of 18F-FDG PET/CT in Patients With Aggressive B-Cell Lymphoma Treated With Anti-CD19 Chimeric Antigen Receptor T Cells

Sesques, Pierre; Tordo, Jérémie; Ferrant, Emmanuelle; More

Clinical Nuclear Medicine. 46(8):627-634, August 2021.

First-in-Human Experience With 177Lu-DOTAGA.(SA.FAPi)2 Therapy in an Uncommon Case of Aggressive Medullary Thyroid Carcinoma Clinically Mimicking as Anaplastic Thyroid Cancer

Ballal, Sanjana; Yadav, Madhav Prasad; Moon, Euy Sung; More

Clinical Nuclear Medicine. 47(6):e444-e445, June 2022.

Decentralized Distributed Multi-institutional PET Image Segmentation Using a Federated Deep Learning Framework

Shiri, Isaac; Vafaei Sadr, Alireza; Amini, Mehdi; More

Clinical Nuclear Medicine. 47(7):606-617, July 2022.

Impact of 68Ga-FAPI-04 PET/CT on Staging and Therapeutic Management in Patients With Digestive System Tumors

Kosmala, Aleksander; Serfling, Sebastian E.; Schlötelburg, Wiebke; More

Clinical Nuclear Medicine. 48(1):35-42, January 2023.

Enhancing Clinical Diagnosis for Patients With Persistent Pulmonary Abnormalities After COVID-19 Infection: The Potential Benefit of 68Ga-FAPI PET/CT

Sviridenko, Anna; Boehm, Anna; di Santo, Gianpaolo; More

Clinical Nuclear Medicine. 47(12):1026-1029, December 2022.